← Back to Clinical Trials
Recruiting NCT02355301

NCT02355301 Improve the Quality of Care in Patients With Orthopaedic Disorders

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT02355301
Status Recruiting
Phase
Sponsor Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Condition Orthopedic Disorder
Study Type OBSERVATIONAL
Enrollment 2,000 participants
Start Date 2015-04-05
Primary Completion 2025-12

Eligibility & Interventions

Sex All sexes
Min Age 1 Year
Max Age 90 Years
Study Type OBSERVATIONAL
Interventions
orthopedic

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 2,000 participants in total. It began in 2015-04-05 with a primary completion date of 2025-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The main objective of the investigators is to improve the quality of care in patients with orthopedic disorders followed in St Luc hospital (Brussels Belgium). To do this, the investigators want to assess the impact of Orthopedic treatments at the structural level (bone structure, muscle, etc.), at the functional level (mobility, strength, stiffness...), on the restriction of activities of patients (walking, make its care daily..) and on the limitation of participation in the life of every day (sport, work, social life, cultural...). This functional evaluation of patients with orthopedic disorders by the ICF model is an original approach rarely used in muscular-skeletal impairments that can very improve the management of these patients and their quality of life. In addition, the investigators associate the harvesting of all medical and computer data collected by high-precision tools in the surgical treatments, to better define the surgical precision and improve the quality of surgical care.

Eligibility Criteria

Inclusion Criteria: * all patients with orthopedic disorders : muscular skeletal impairment Exclusion Criteria: Dementia patients with multiple disorders Patients who do not understand the instructions

Contact & Investigator

Central Contact

Christine DJ Detrembleur, PhD

✉ christine.detrembleur@uclouvain.be

📞 003227645365

Principal Investigator

Olivier Cornu, MD,PhD

PRINCIPAL INVESTIGATOR

Cliniques universitaires St Luc Brussels

Frequently Asked Questions

Who can join the NCT02355301 clinical trial?

This trial is open to participants of all sexes, aged 1 Year or older, up to 90 Years, studying Orthopedic Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT02355301 currently recruiting?

Yes, NCT02355301 is actively recruiting participants. Contact the research team at christine.detrembleur@uclouvain.be for enrollment information.

Where is the NCT02355301 trial being conducted?

This trial is being conducted at Brussels, Belgium.

Who is sponsoring the NCT02355301 clinical trial?

NCT02355301 is sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain. The principal investigator is Olivier Cornu, MD,PhD at Cliniques universitaires St Luc Brussels. The trial plans to enroll 2,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology